The new facility will support a robust pipeline of biopharmaceuticals, including a biosimilar to Enbrel® for the treatment of rheumatoid arthritisChalfont St Giles, UK and Changxing, Zhejiang, China – 23 January 2018 – Clover Biopharmaceuticals, a biotechnology company focused on developing novel
https://www.genewsroom.com/press-releases/clover-biopharmaceuticals-selects-ges-flexfactory-biomanufacturing-platform-its-new